PT99674A - Processo para a preparacao de 5-amino-5,6,7,8-tetra-hidroquinolinas e de composicoes farmaceuticas que as contem - Google Patents

Processo para a preparacao de 5-amino-5,6,7,8-tetra-hidroquinolinas e de composicoes farmaceuticas que as contem

Info

Publication number
PT99674A
PT99674A PT99674A PT9967491A PT99674A PT 99674 A PT99674 A PT 99674A PT 99674 A PT99674 A PT 99674A PT 9967491 A PT9967491 A PT 9967491A PT 99674 A PT99674 A PT 99674A
Authority
PT
Portugal
Prior art keywords
arylalkyl
alkyl
formula
hydrogen
chem
Prior art date
Application number
PT99674A
Other languages
English (en)
Other versions
PT99674B (pt
Inventor
Richard Charles Effland
David M Fink
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of PT99674A publication Critical patent/PT99674A/pt
Publication of PT99674B publication Critical patent/PT99674B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Quinoline Compounds (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT99674A 1990-12-03 1991-12-03 Processo para a preparacao de 5-amino-5,6,7,8-tetra-hidroquinolinas e de composicoes farmaceuticas que as contem PT99674B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/620,811 US5110815A (en) 1990-12-03 1990-12-03 5-amino-5,6,7,8-tetrahydroquinolines and related compounds and pharmaceutical use

Publications (2)

Publication Number Publication Date
PT99674A true PT99674A (pt) 1992-10-30
PT99674B PT99674B (pt) 1999-05-31

Family

ID=24487491

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99674A PT99674B (pt) 1990-12-03 1991-12-03 Processo para a preparacao de 5-amino-5,6,7,8-tetra-hidroquinolinas e de composicoes farmaceuticas que as contem

Country Status (17)

Country Link
US (2) US5110815A (pt)
EP (1) EP0489379B1 (pt)
JP (1) JP3090514B2 (pt)
KR (1) KR100235506B1 (pt)
AT (1) ATE168371T1 (pt)
AU (1) AU639875B2 (pt)
CA (1) CA2056793C (pt)
DE (1) DE69129790T2 (pt)
DK (1) DK0489379T3 (pt)
ES (1) ES2119752T3 (pt)
FI (1) FI915653A (pt)
IE (1) IE914183A1 (pt)
NO (1) NO914734L (pt)
NZ (1) NZ240803A (pt)
PT (1) PT99674B (pt)
TW (1) TW211003B (pt)
ZA (1) ZA919480B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL112568A0 (en) * 1994-02-10 1995-05-26 Wyeth John & Brother Ltd Substituted quinolines, their preparation and pharmaceutical compositions containing them
IL112567A (en) * 1994-02-10 2000-02-29 Wyeth John & Brother Ltd Substituted quinolines their preparation and pharmaceutical compositions containing them
IL112566A (en) * 1994-02-10 2000-10-31 Wyeth John & Brother Ltd Substituted quinolinones and pharmaceutical compositions containing them
KR0158065B1 (ko) * 1995-05-29 1998-12-01 스기야마 가즈히코 반도체 집적회로장치 및 그 제조방법
CN1535682A (zh) 1998-09-30 2004-10-13 ����ҩƷ��ҵ��ʽ���� 改善膀胱排泄能力的药物
TWI301760B (en) * 2004-02-27 2008-10-11 Merz Pharma Gmbh & Co Kgaa Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789678A (en) * 1986-08-25 1988-12-06 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing α-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl)alkanones and related compounds
US4942168A (en) * 1987-07-13 1990-07-17 Hoechst-Roussel Pharmaceuticals Inc. Hydroxyquinoline amines, and method of enhancing memory in mammals
EP0361489A3 (en) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha Novel 3,4-diaminoquinoline and pyridine compounds
JPH0322011A (ja) * 1989-06-19 1991-01-30 Nec Corp キーボード入力データ処理方式

Also Published As

Publication number Publication date
ZA919480B (en) 1992-08-26
KR920012036A (ko) 1992-07-25
FI915653A0 (fi) 1991-11-29
US5110815A (en) 1992-05-05
CA2056793A1 (en) 1992-06-04
US5310914A (en) 1994-05-10
DE69129790T2 (de) 1999-05-06
AU639875B2 (en) 1993-08-05
JPH04290872A (ja) 1992-10-15
NO914734D0 (no) 1991-12-02
DK0489379T3 (da) 1999-04-19
JP3090514B2 (ja) 2000-09-25
EP0489379B1 (en) 1998-07-15
DE69129790D1 (de) 1998-08-20
TW211003B (pt) 1993-08-11
ATE168371T1 (de) 1998-08-15
IE914183A1 (en) 1992-06-03
PT99674B (pt) 1999-05-31
ES2119752T3 (es) 1998-10-16
CA2056793C (en) 2003-03-11
FI915653A (fi) 1992-06-04
KR100235506B1 (ko) 1999-12-15
EP0489379A1 (en) 1992-06-10
AU8835291A (en) 1992-06-04
NO914734L (no) 1992-06-04
NZ240803A (en) 1994-07-26

Similar Documents

Publication Publication Date Title
IL120266A (en) Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
DE69021755T2 (de) Benzopyranderivate und Verfahren zu ihrer Herstellung.
PT93527A (pt) Processo para a preparacao de derivados de xantina
PT92806A (pt) Processo para a preparacao de derivados de 2-amino-pirimidinona e de composicoes farmaceuticas que os contem
PT80003B (pt) Processo para a preparacao de derivados da pirido-benzotiazina com elevada actividade anti-microbiana
ES2051479T3 (es) Uso de imidazoles substituidos en 4 para disminuir la presion intraocular.
PT90725A (pt) Processo para a preparacao de novos compostos cefem
PT90986A (pt) Processo para a preparacao de esteres de estramustina e de composicoes farmaceuticas que os contem
ES2055235T3 (es) Composicion anti-inflamatoria y/o antialergica que comprende derivados de glutation.
PT99674A (pt) Processo para a preparacao de 5-amino-5,6,7,8-tetra-hidroquinolinas e de composicoes farmaceuticas que as contem
DK0420121T3 (da) Antitumormiddel
FI935798A0 (fi) Alkylsubstituerade heterocykliska foereningar
DK0420224T3 (da) Anthihepatopatisk middel

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920617

FG3A Patent granted, date of granting

Effective date: 19990210

MM3A Annulment or lapse

Effective date: 20050810